OQS
RCUS icon

Occudo Quantitative Strategies’s Arcus Biosciences RCUS Stock Holding History

Occudo Quantitative Strategies’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-28,783
Closed -$585K – 1257
2023
Q2 		$585K Buy
+28,783
New +$548K 0.06% 497
2022
Q4 		– Sell
-28,451
Closed -$744K – 1303
2022
Q3 		$744K Buy
+28,451
New +$752K 0.06% 526

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Occudo Quantitative Strategies's RCUS Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of Arcus Biosciences (RCUS) in Q3 2023, closing a stake of 28,783 shares — an estimated $585K sold.

Occudo Quantitative Strategies first reported a position in RCUS in Q3 2022 and held it in 2 quarters. The position peaked at $744K in Q3 2022. 187 funds tracked by Wall St. Rank hold RCUS as of Q3 2023.

  • Occudo Quantitative Strategies reported no remaining Arcus Biosciences position as of Q3 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 28,783 Arcus Biosciences shares in Q3 2023, an estimated $585K.
  • Occudo Quantitative Strategies first reported a position in Arcus Biosciences in Q3 2022 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Arcus Biosciences position peaked at $744K in Q3 2022.
  • 187 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.